Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From H-CYTE Inc.
Finance Watch: Seed/Series A Financings Benefit As Big Crossover Rounds Slow
Silicon Valley Bank data show a pullback in crossover financings but an increase in seed and series A venture capital rounds. In recent private company financings, CRO Novotech raised $760m. In public company financings, Eleusis will merge with a SPAC and the Bausch + Lomb IPO is on file with the SEC.
Keeping Track: Seqirus Pandemic Flu Vaccine Approved; Trevena Resubmits Oliceridine
The latest drug development news and highlights from our US FDA Performance Tracker.
Medovex Plans US IDE Trial For Its DenerveX Spine Surgery Device
DenerveX is a unique surgical tool used to ablate the nerve and capsular tissue on the posterior surface of the facet joint. preventing the nerve from reattaching with the goal of creating lasting relief from back pain that otherwise might require spinal fusion and/or treatment with opiate drugs.
Medical Device Deals Update, February 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
- Blue Zone Health
- Medovex Corporation
- Regenerative Medicine Solutions, LLC
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.